| Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer (NCT03091842) | University of Southern California | 2019-07-29 |
| Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer (NCT03971409) | Laura Huppert, MD, BA | 2019-07-08 |
| Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer (NCT03566485) | Vanderbilt-Ingram Cancer Center | 2018-07-10 |
| Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners (NCT03112668) | Rutgers, The State University of New Jersey | 2017-12-06 |
| 4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer (NCT03364348) | George W. Sledge Jr. | 2017-10-30 |
| Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer (NCT03102866) | Ohio State University Comprehensive Cancer Center | 2017-08-30 |
| Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors (NCT03284346) | University of Southern California | 2017-08-17 |
| Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer (NCT03128619) | Jonsson Comprehensive Cancer Center | 2017-08-02 |
| Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer (NCT02860000) | Mayo Clinic | 2017-07-06 |
| Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery (NCT03044730) | Northwestern University | 2017-05-25 |
| Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer (NCT03139435) | Wake Forest University Health Sciences | 2017-05-11 |
| Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) (NCT03025139) | Jonsson Comprehensive Cancer Center | 2017-02-20 |
| Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery (NCT02760030) | Ohio State University Comprehensive Cancer Center | 2017-02-16 |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors (NCT02897375) | Emory University | 2016-10-24 |
| S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) (NCT02728596) | SWOG Cancer Research Network | 2016-10-07 |
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission (NCT02780401) | University of Washington | 2016-09-02 |
| MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment (NCT02702830) | Wake Forest University Health Sciences | 2016-08-25 |
| Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer (NCT03050463) | Stanford University | 2016-08-01 |
| Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer (NCT02827877) | City of Hope Medical Center | 2016-07-15 |
| Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin (NCT02677389) | University of Wisconsin, Madison | 2016-07-01 |
| Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors (NCT02662335) | Fred Hutchinson Cancer Center | 2016-05-01 |
| eHealth Weight Loss Program in African American Breast Cancer Survivors (NCT02699983) | Rutgers, The State University of New Jersey | 2016-01-08 |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations (NCT02646319) | Mayo Clinic | 2016-01-01 |
| Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy (NCT02445391) | ECOG-ACRIN Cancer Research Group | 2015-10-20 |
| Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity (NCT02566408) | Case Comprehensive Cancer Center | 2015-10-14 |
| High-Intensity Interval Training for Stage I-III Breast Cancer Patients (NCT02454777) | University of Southern California | 2015-09-29 |
| Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors (NCT03198286) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-08-01 |
| Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer (NCT02488967) | NRG Oncology | 2015-07-26 |
| 18F-FSPG PET/CT for Cancer Patients on Therapy (NCT02599194) | Andrei Iagaru | 2015-07-01 |
| Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer (NCT02203552) | Ohio State University Comprehensive Cancer Center | 2015-06-23 |
| Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer (NCT02157051) | University of Washington | 2015-06-01 |
| Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors (NCT03039140) | Ohio State University Comprehensive Cancer Center | 2015-05-14 |
| Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer (NCT02400060) | Ohio State University Comprehensive Cancer Center | 2015-03-26 |
| Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer (NCT02315196) | Rutgers, The State University of New Jersey | 2015-02-25 |
| Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery (NCT02219789) | Mayo Clinic | 2014-12-05 |
| Phase II Study of Everolimus Beyond Progression (NCT02269670) | Emory University | 2014-11-25 |
| Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer (NCT02273752) | Emory University | 2014-11-01 |
| Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus (NCT02015559) | Jonsson Comprehensive Cancer Center | 2014-10-08 |
| Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery (NCT01816035) | University of Washington | 2014-06-01 |
| BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx (NCT02038010) | Northwestern University | 2014-05-21 |
| Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy (NCT02023008) | Wake Forest University Health Sciences | 2014-05-01 |
| Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery (NCT01953588) | Alliance for Clinical Trials in Oncology | 2014-02-27 |
| Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy (NCT02002533) | Gary Morrow | 2014-02-03 |
| Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy (NCT01941784) | Wake Forest University Health Sciences | 2013-11-25 |
| PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer (NCT01712815) | University of Southern California | 2013-11-22 |
| Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer (NCT01869764) | Wake Forest University Health Sciences | 2013-11-01 |
| Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT02046421) | University of Chicago | 2013-11-01 |
| Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer (NCT01959490) | Case Comprehensive Cancer Center | 2013-09-24 |
| Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer (NCT01730833) | City of Hope Medical Center | 2013-07-17 |
| Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer (NCT01868503) | Stanford University | 2013-07-01 |
| A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) (NCT01824836) | ECOG-ACRIN Cancer Research Group | 2013-06-11 |
| Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer (NCT01897441) | Albert Einstein College of Medicine | 2013-06-01 |
| Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery (NCT01754519) | Roswell Park Cancer Institute | 2013-05-01 |
| Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors (NCT01849250) | National Cancer Institute (NCI) | 2013-05-01 |
| Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer (NCT01818063) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-04-25 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer (NCT01776008) | National Cancer Institute (NCI) | 2013-01-01 |
| Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer (NCT01750073) | University of Nebraska | 2012-12-07 |
| Light-Scattering Spectroscopy for Detection of Breast Cancer (NCT01755208) | University of Southern California | 2012-11-21 |
| Phase I: At-Home Support for Rural Women Using Group Video Calling (NCT01672684) | Stanford University | 2012-10-01 |
| Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer (NCT02370264) | University of Southern California | 2012-10-01 |
| Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery (NCT01705340) | National Cancer Institute (NCI) | 2012-09-01 |
| Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors (NCT01628887) | City of Hope Medical Center | 2012-08-01 |
| Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer (NCT01632332) | Mayo Clinic | 2012-07-09 |
| Exercise Program for Early Breast Cancer Survivors (NCT01140282) | University of Southern California | 2012-05-21 |
| Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant (NCT01558778) | Roswell Park Cancer Institute | 2012-05-01 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer (NCT01525966) | City of Hope Medical Center | 2012-02-15 |
| Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery (NCT01483196) | Wake Forest University Health Sciences | 2012-01-01 |
| PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer (NCT01697293) | Prescient Therapeutics, Ltd. | 2012-01-01 |
| Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole (NCT01478477) | Ohio State University Comprehensive Cancer Center | 2011-10-04 |
| FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer (NCT01928186) | University of Washington | 2011-09-01 |
| Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer (NCT01368263) | Washington University School of Medicine | 2011-09-01 |
| Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients (NCT01372579) | Northwestern University | 2011-08-01 |
| Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer (NCT01355393) | University of Washington | 2011-07-01 |
| MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer (NCT01319539) | National Cancer Institute (NCI) | 2011-04-01 |
| Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer (NCT01277757) | National Cancer Institute (NCI) | 2011-03-01 |
| Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer (NCT01385280) | University of Arizona | 2011-02-01 |
| Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms (NCT01194440) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-02-01 |
| Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer (NCT01729832) | Ohio State University Comprehensive Cancer Center | 2011-01-10 |
| Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT01281150) | National Cancer Institute (NCI) | 2011-01-01 |
| Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer (NCT01288261) | University of Arizona | 2011-01-01 |
| Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery (NCT01292083) | University of Southern California | 2011-01-01 |
| Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer (NCT01417286) | Rutgers, The State University of New Jersey | 2010-12-21 |
| Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery (NCT01276496) | National Cancer Institute (NCI) | 2010-12-01 |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer (NCT01238133) | National Cancer Institute (NCI) | 2010-12-01 |
| Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel (NCT01243541) | Northwestern University | 2010-11-03 |
| Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer (NCT01245205) | National Cancer Institute (NCI) | 2010-11-01 |
| RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer (NCT01149356) | National Cancer Institute (NCI) | 2010-10-01 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT01233505) | National Cancer Institute (NCI) | 2010-10-01 |
| Endoscopic Breast Surgery in Treating Patients With Breast Cancer (NCT01222377) | University of Southern California | 2010-09-01 |
| Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload (NCT01159067) | City of Hope Medical Center | 2010-07-01 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258) | University of Southern California | 2010-06-01 |
| Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer (NCT01151449) | National Cancer Institute (NCI) | 2010-06-01 |
| RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors (NCT01158274) | National Cancer Institute (NCI) | 2010-06-01 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer (NCT01051401) | Wake Forest University Health Sciences | 2010-01-01 |
| Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel (NCT01050075) | City of Hope Medical Center | 2010-01-01 |
| MUC1 Vaccine for Triple-negative Breast Cancer (NCT00986609) | Joseph Baar, MD, PhD | 2009-08-19 |
| Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain (NCT01013337) | Abramson Cancer Center at Penn Medicine | 2009-05-01 |